AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 APR 11 - (NewsRx.com & NewsRx.net) --
In continuing efforts to curb the global spread of AIDS, The International AIDS Vaccine Initiative (IAVI) and Therion Biologics will collaborate as new partners to develop prophylactic AIDS vaccines for developing countries, specifically India.
The unique partnership brings together Therion's vaccine technology, IAVI's development capabilities, and Indian scientists focused in AIDS research.
Under terms of the collaboration, IAVI will fully fund Therion's work in designing, engineering, and manufacturing a novel vaccine specific for the strain of HIV (subtype C) common to India. Pending necessary approvals from appropriate regulatory agencies, IAVI intends to accelerate this vaccine into clinical trials.
The announcement followed the March 20, 2001, signing of an agreement between IAVI and India's Ministry of Health and Family Welfare for a commitment to ...